country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-N14037

Copy Link Print Information

Chondramide C

Chondramide C has anti-candida, Henson yeast, lipids yeast, ball-like yeast and other fungal activities, but has no anti-Gram positive and negative bacteria activities.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 172430-62-5
Formule: C₃₅H₄₄N₄O₆
Masse moléculaire:616.75

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (272 KB)

Chondramide C Chemical Structure

CAS No.: 172430-62-5

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- Cellular Effect
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

Chondramide C has anti-candida, Henson yeast, lipids yeast, ball-like yeast and other fungal activities, but has no anti-Gram positive and negative bacteria activities^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
MCF7	IC50	23 nM	Cytotoxicity against human MCF-7 cells by cell viability assay. Cytotoxicity against human MCF-7 cells by cell viability assay.	22475347
HT-29	IC50	21 nM	Cytotoxicity against human HT-29 cells by cell viability assay. Cytotoxicity against human HT-29 cells by cell viability assay.	22475347
MCF7	IC50	0.023 μM	Cytotoxicity of natural Chondramide C against human MCF-7 breast cancer cells. Cytotoxicity of natural Chondramide C against human MCF-7 breast cancer cells.	20148556
HT-29	IC50	0.021 μM	Cytotoxicity of natural Chondramide C against human HT-29 colorectal cancer cells. Cytotoxicity of natural Chondramide C against human HT-29 colorectal cancer cells.	20148556
MCF7	IC50	0.083 μM	Cytotoxicity of Synthetic Chondramide C against human MCF-7 breast cancer cells. Cytotoxicity of Synthetic Chondramide C against human MCF-7 breast cancer cells.	20148556
HT-29	IC50	0.031 μM	Cytotoxicity of Synthetic Chondramide C against human HT-29 colorectal cancer cells. Cytotoxicity of Synthetic Chondramide C against human HT-29 colorectal cancer cells.	20148556

In Vitro

Anti-cancerOthers

Anti-cancer

Chondramide C is cytotoxic to MCF-7 and HT-29 cells, with IC₅₀ values of 0.023 and 0.021 μM for the natural product and 0.083 and 0.031 μM for the synthetic product, respectively^[1]^[3].

Others

Chondramide C (10 mM; 6 h) reduces actin filaments in HeLa cells^[2].
Chondramide C (compound 3c) (24 h) disrupts actin organization in BSC-1 cells, leading to loss of stress fibers and formation of perinuclear actin aggregates^[3].
Chondramide C can serve as an intermediate for the synthesis of derivatives with anticancer activity^[4].
Chondramide C shows strong binding affinity to the spike proteins of SARS-CoV-2 wild-type, N501Y, E484K, and D614G-I472V variants in molecular docking simulations, and can bind to key amino acid sites of the spike protein through molecular interactions such as hydrogen bonds and π-π stacking^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 172430-62-5
Masse moléculaire 616.75
Formule C₃₅H₄₄N₄O₆
SMILES

O=C(C[C@H](C1=CC=C(O)C=C1)NC([C@@H](CC2=CNC3=C2C=CC=C3)N4C)=O)O[C@H](C)[C@H](C)/C=C(C)\C[C@H](C)C(N[C@@H](C)C4=O)=O
Structure Classification
- Others
Initial Source
- Microorganism
Myxobacterium Chondromyces crocatus
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (272 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Ulrike Eggert, et al. Chondramide C: synthesis, configurational assignment, and structure-activity relationship studies. Angew Chem Int Ed Engl. 2008;47(34):6478-82. [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis